Trials / Completed
CompletedNCT03190668
Skeletal Muscle and Adipose Tissue Study
Skeletal Muscle and Adipose Tissue Concentrations of Cefazolin Comparing Two Different Dosing Regimens During Pediatric Posterior Spinal Fusion Surgery
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 12 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to compare the current standard of care for prophylactic Cefazolin administered every 3 hours intravenously with continuous infusion of Cefazolin during pediatric spinal surgery.
Detailed description
Determine the skeletal muscle and adipose tissue disposition of prophylactic Cefazolin using microdialysis sampling in a cohort of patients diagnosed with idiopathic scoliosis undergoing posterior spinal fusion (PSF) for administration of Cefazolin by either continuous infusion or intermittent bolus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bolus dose of Cefazolin | Mode of Cefazolin administration will be a intermittent bolus |
| DRUG | Continuous Cefazolin drip | Mode of Cefazolin administration will be a continuous drip |
| DEVICE | Paraspinal muscle microdialysis catheters | Two dialysis probes will be inserted into a paraspinal muscle |
| DEVICE | Subcutaneous microdialysis catheters | Two dialysis probes will be inserted into a paraspinal subcutaneous region |
Timeline
- Start date
- 2018-05-29
- Primary completion
- 2022-06-23
- Completion
- 2022-06-23
- First posted
- 2017-06-19
- Last updated
- 2023-07-11
- Results posted
- 2023-07-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03190668. Inclusion in this directory is not an endorsement.